Medication for addiction treatment and acute care utilization in HIV-positive adults with substance use disorders
Autor: | K. Thakarar, Alexander Y. Walley, Alicia S. Ventura, Mari-Lynn Drainoni, Michael Winter, Timothy Heeren, Meg Sullivan, Richard Saitz |
---|---|
Rok vydání: | 2019 |
Předmět: |
Adult
Male medicine.medical_specialty Health (social science) Social Psychology media_common.quotation_subject Human immunodeficiency virus (HIV) HIV Infections medicine.disease_cause Article 03 medical and health sciences Health services 0302 clinical medicine Acute care mental disorders medicine Humans 030212 general & internal medicine Social determinants of health Psychiatry Addiction treatment media_common 030505 public health business.industry Addiction Public Health Environmental and Occupational Health virus diseases Middle Aged Opioid-Related Disorders Hiv seropositivity Alcoholism Female Substance use Emergency Service Hospital 0305 other medical science business psychological phenomena and processes |
Zdroj: | AIDS Care |
ISSN: | 1360-0451 0954-0121 |
Popis: | Medication for addiction treatment (MAT) could reduce acute care utilization in HIV-positive individuals with substance use disorders. The study objective was to determine if HIV-positive people with substance use disorders treated with MAT report less acute care utilization than those not receiving MAT. We assessed the association between MAT and acute care utilization among HIV-positive individuals with alcohol or opioid use disorder. Acute care utilization 6 months later was defined as any past 3-month self-reported (1) emergency department (ED) visit and (2) hospitalization. Of 153 participants, 88% had alcohol use disorder, 41% had opioid use disorder, and 48 (31%) were treated with MAT. Fifty-five (36%) participants had an ED visit and 38 (25%) participants had a hospitalization. MAT was not associated with an ED visit (AOR 1.12, 95% CI 0.46-2.75) or hospitalization (AOR 1.09, 95% CI 0.39-3.04). MAT was not associated with acute care utilization. These results highlight the need to increase MAT prescribing in HIV-positive individuals with substance use disorders, and to address the many factors that influence acute care utilization. |
Databáze: | OpenAIRE |
Externí odkaz: |